Stratum Biosciences: Funding, Investors & Team (Oct 2026)
Stratum Biosciences is a biotechnology company that develops and commercializes advanced wound care and regenerative medicine products derived from human tissue. The company focuses on solutions that support healing for burns, chronic wounds, and surgical applications, using biologically active materials to promote tissue repair. Its product portfolio typically includes skin substitutes and amniotic membrane-based therapies designed to improve clinical outcomes and reduce recovery time. Stratum Biosciences serves healthcare providers such as hospitals, clinics, and surgical centers, offering products that integrate into existing treatment protocols. The company operates within the broader regenerative medicine sector, emphasizing innovation, quality standards, and compliance with healthcare regulations.
Stratum Biosciences has raised $2.0M across 1 funding round on record, the most recent a Seed of $2.0M announced in Mar 2026.
That round is below the $6.0M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Stratum Biosciences Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Stratum Biosciences Funding Rounds
Stratum Biosciences Founders and Leadership Team
Contact details for the Stratum Biosciences team: 1 has a LinkedIn profile.
Start 14-day free trial →Stratum Biosciences Funding Compared to Other Artificial Intelligence Startups
Stratum Biosciences' latest round of $2.0M is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Stratum Biosciences in Artificial Intelligence and New York
Companies Similar to Stratum Biosciences
Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…
Nyne is the people data company. We deploy tens of millions of autonomous agents across the open web to…
Vinci utilizes generative artificial intelligence to create hardware design. Its services cover the design,…
Siena AI is an innovative customer service platform designed specifically for commerce. It combines the…
Factory is a developer of an AI-based platform for computer codes and software engineering. Its platform…
Ocular is a Cloud and Artificial Intelligence company, backed by Y Combinator, bringing Enterprise AI and…
Ghost is a consumer hardware and software company building a private, local-first computing system for…
Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial…
The EnCharge AI platform provides a reliable computing solution that enables the utilization of highly…
The hardest unsolved problem in robotics isn't perception or locomotion, it's dexterity. Tangent Robotics…
Autopoiesis Sciences creates advanced AI models that aim to enable groundbreaking scientific advancements…
Stratum Biosciences Funding FAQs
What does Stratum Biosciences do?
Stratum Biosciences is a biotechnology company that develops and commercializes advanced wound care and regenerative medicine products derived from human tissue. The company focuses on solutions that support healing for burns, chronic wounds, and surgical applications, using biologically active materials to promote tissue repair. Its product portfolio typically includes skin substitutes and amniotic membrane-based therapies designed to improve clinical outcomes and reduce recovery time. Stratum Biosciences serves healthcare providers such as hospitals, clinics, and surgical centers, offering products that integrate into existing treatment protocols. The company operates within the broader regenerative medicine sector, emphasizing innovation, quality standards, and compliance with healthcare regulations.
How much funding has Stratum Biosciences raised?
Stratum Biosciences has raised $2.0M across 1 round on record. The most recent is a Seed of $2.0M announced in Mar 2026.
When did Stratum Biosciences last raise funding?
Stratum Biosciences' most recent funding round on record is a Seed of $2.0M, announced in Mar 2026.
Who founded Stratum Biosciences?
FundedIQ lists Ross Lane Pearlman (Founder) at Stratum Biosciences.
Where is Stratum Biosciences headquartered?
Stratum Biosciences is based in New York, New York, United States.
How many employees does Stratum Biosciences have?
Stratum Biosciences is in the 11-50 employee band.
How does Stratum Biosciences' funding compare to other Artificial Intelligence startups?
Stratum Biosciences' latest round of $2.0M is below the $6.0M median round size for Artificial Intelligence companies on FundedIQ across 7,241 tracked companies over the last two years.
About FundedIQ's Stratum Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Stratum Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.